Diastereoselective synthesis of cyclic tetrapeptide pseudoxylallemycin A illuminates the impact of base during macrolactamization
Therapeutic agents with unique molecular structures and new mechanisms of action are needed to confront the phenomenon of multidrug resistance among bacteria. Pseudoxylallemycins, cyclic tetrapeptide (CTP) natural products, have exhibited modest antibiotic activity, but their synthesis has proven ch...
Saved in:
Published in | Organic & biomolecular chemistry Vol. 21; no. 5; pp. 156 - 169 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
01.02.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 1477-0520 1477-0539 1477-0539 |
DOI | 10.1039/d2ob02126a |
Cover
Abstract | Therapeutic agents with unique molecular structures and new mechanisms of action are needed to confront the phenomenon of multidrug resistance among bacteria. Pseudoxylallemycins, cyclic tetrapeptide (CTP) natural products, have exhibited modest antibiotic activity, but their synthesis has proven challenging. Inherent ring strain in CTPs decreases the rate of cyclization in lieu of polymerization and racemization pathways, which has resulted in previous syntheses describing mixtures of diastereomers containing predominantly an undesired epimer. We have optimized the cyclization step of pseudoxylallemycin A to favor production of the natural diastereomer; notably, variation of the base, temperature, and solvent with peptide coupling reagent propylphosphonic anhydride (T3P) afforded exquisite selectivity for the natural product in as high as 97 : 3 DR, and our conditions can provide the natural product in up to 32% overall yield through 8 steps. Employing weaker bases than those typically used in peptide coupling reactions led to the greatest improvement in diastereoselectivity, and these studies demonstrated that the identity of the amine base has enormous impact on the rate of C-terminal epimerization when T3P is used, a variable usually considered of lesser consequence when combined with typical amide coupling reagents. Toward fully characterizing pseudoxylallemycin stereoisomers, variable temperature NMR was described as a tool to more clearly analyze CTPs that exhibit multiple conformational states. These synthetic and spectroscopic insights were applied toward synthesizing several natural product analogues, and their antibacterial activity was examined using microdilution assays.
Amine bases go beyond their typical proton shuttle role in the macrolactamization of pseudoxylallemycin, as we diastereoselectively synthesize the natural product and analogues thereof to explore their characterization and biological activity. |
---|---|
AbstractList | Therapeutic agents with unique molecular structures and new mechanisms of action are needed to confront the phenomenon of multidrug resistance among bacteria. Pseudoxylallemycins, cyclic tetrapeptide (CTP) natural products, have exhibited modest antibiotic activity, but their synthesis has proven challenging. Inherent ring strain in CTPs decreases the rate of cyclization in lieu of polymerization and racemization pathways, which has resulted in previous syntheses describing mixtures of diastereomers containing predominantly an undesired epimer. We have optimized the cyclization step of pseudoxylallemycin A to favor production of the natural diastereomer; notably, variation of the base, temperature, and solvent with peptide coupling reagent propylphosphonic anhydride (T3P) afforded exquisite selectivity for the natural product in as high as 97 : 3 DR, and our conditions can provide the natural product in up to 32% overall yield through 8 steps. Employing weaker bases than those typically used in peptide coupling reactions led to the greatest improvement in diastereoselectivity, and these studies demonstrated that the identity of the amine base has enormous impact on the rate of C-terminal epimerization when T3P is used, a variable usually considered of lesser consequence when combined with typical amide coupling reagents. Toward fully characterizing pseudoxylallemycin stereoisomers, variable temperature NMR was described as a tool to more clearly analyze CTPs that exhibit multiple conformational states. These synthetic and spectroscopic insights were applied toward synthesizing several natural product analogues, and their antibacterial activity was examined using microdilution assays.
Amine bases go beyond their typical proton shuttle role in the macrolactamization of pseudoxylallemycin, as we diastereoselectively synthesize the natural product and analogues thereof to explore their characterization and biological activity. Therapeutic agents with unique molecular structures and new mechanisms of action are needed to confront the phenomenon of multidrug resistance among bacteria. Pseudoxylallemycins, cyclic tetrapeptide (CTP) natural products, have exhibited modest antibiotic activity, but their synthesis has proven challenging. Inherent ring strain in CTPs decreases the rate of cyclization in lieu of polymerization and racemization pathways, which has resulted in previous syntheses describing mixtures of diastereomers containing predominantly an undesired epimer. We have optimized the cyclization step of pseudoxylallemycin A to favor production of the natural diastereomer; notably, variation of the base, temperature, and solvent with peptide coupling reagent propylphosphonic anhydride (T3P) afforded exquisite selectivity for the natural product in as high as 97 : 3 DR, and our conditions can provide the natural product in up to 32% overall yield through 8 steps. Employing weaker bases than those typically used in peptide coupling reactions led to the greatest improvement in diastereoselectivity, and these studies demonstrated that the identity of the amine base has enormous impact on the rate of C-terminal epimerization when T3P is used, a variable usually considered of lesser consequence when combined with typical amide coupling reagents. Toward fully characterizing pseudoxylallemycin stereoisomers, variable temperature NMR was described as a tool to more clearly analyze CTPs that exhibit multiple conformational states. These synthetic and spectroscopic insights were applied toward synthesizing several natural product analogues, and their antibacterial activity was examined using microdilution assays. Therapeutic agents with unique molecular structures and new mechanisms of action are needed to confront the phenomenon of multidrug resistance among bacteria. Pseudoxylallemycins, cyclic tetrapeptide (CTP) natural products, have exhibited modest antibiotic activity, but their synthesis has proven challenging. Inherent ring strain in CTPs decreases the rate of cyclization in lieu of polymerization and racemization pathways, which has resulted in previous syntheses describing mixtures of diastereomers containing predominantly an undesired epimer. We have optimized the cyclization step of pseudoxylallemycin A to favor production of the natural diastereomer; notably, variation of the base, temperature, and solvent with peptide coupling reagent propylphosphonic anhydride (T3P) afforded exquisite selectivity for the natural product in as high as 97 : 3 DR, and our conditions can provide the natural product in up to 32% overall yield through 8 steps. Employing weaker bases than those typically used in peptide coupling reactions led to the greatest improvement in diastereoselectivity, and these studies demonstrated that the identity of the amine base has enormous impact on the rate of C-terminal epimerization when T3P is used, a variable usually considered of lesser consequence when combined with typical amide coupling reagents. Toward fully characterizing pseudoxylallemycin stereoisomers, variable temperature NMR was described as a tool to more clearly analyze CTPs that exhibit multiple conformational states. These synthetic and spectroscopic insights were applied toward synthesizing several natural product analogues, and their antibacterial activity was examined using microdilution assays.Therapeutic agents with unique molecular structures and new mechanisms of action are needed to confront the phenomenon of multidrug resistance among bacteria. Pseudoxylallemycins, cyclic tetrapeptide (CTP) natural products, have exhibited modest antibiotic activity, but their synthesis has proven challenging. Inherent ring strain in CTPs decreases the rate of cyclization in lieu of polymerization and racemization pathways, which has resulted in previous syntheses describing mixtures of diastereomers containing predominantly an undesired epimer. We have optimized the cyclization step of pseudoxylallemycin A to favor production of the natural diastereomer; notably, variation of the base, temperature, and solvent with peptide coupling reagent propylphosphonic anhydride (T3P) afforded exquisite selectivity for the natural product in as high as 97 : 3 DR, and our conditions can provide the natural product in up to 32% overall yield through 8 steps. Employing weaker bases than those typically used in peptide coupling reactions led to the greatest improvement in diastereoselectivity, and these studies demonstrated that the identity of the amine base has enormous impact on the rate of C-terminal epimerization when T3P is used, a variable usually considered of lesser consequence when combined with typical amide coupling reagents. Toward fully characterizing pseudoxylallemycin stereoisomers, variable temperature NMR was described as a tool to more clearly analyze CTPs that exhibit multiple conformational states. These synthetic and spectroscopic insights were applied toward synthesizing several natural product analogues, and their antibacterial activity was examined using microdilution assays. |
Author | Zhang, Jieyu Fumo, Vincent M O'Reilly, Matthew C Roberts, R. Charlie |
AuthorAffiliation | Department of Chemistry Villanova University |
AuthorAffiliation_xml | – sequence: 0 name: Department of Chemistry – sequence: 0 name: Villanova University |
Author_xml | – sequence: 1 givenname: Vincent M surname: Fumo fullname: Fumo, Vincent M – sequence: 2 givenname: R. Charlie surname: Roberts fullname: Roberts, R. Charlie – sequence: 3 givenname: Jieyu surname: Zhang fullname: Zhang, Jieyu – sequence: 4 givenname: Matthew C surname: O'Reilly fullname: O'Reilly, Matthew C |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36628602$$D View this record in MEDLINE/PubMed |
BookMark | eNptkktv1TAQhS1URB-wYQ-yxAYh3eLYjpMsLy2USpW6gXXk2BNw5djB41SEHf8ct7cPqWI1I_k7x54zPiR7IQYg5HXFjismuo-Wx4Hxiiv9jBxUsmk2rBbd3kPP2T45RLxirOoaJV-QfaEUbxXjB-TvqdOYIUFE8GCyuwaKa8g_AR3SOFKzGu8MzZCTnmHOzgKdERYbf69eew_TalygW-q8XyYXdAakRU7dNGuTbywGjUDtklz4QSdtUvTlQE_uj84uhpfk-ag9wqu7ekS-f_n87eTr5uLy7Pxke7ExgstqA2poamalGVTdKV16wYfa6rFpoe6kNVbXDBhXI-ej4ba1sgXRlsq1lHIQR-T9zndO8dcCmPvJoQHvdYC4YM9LNFKKplMFffcEvYpLCuV1hWoq3vBye6He3lHLMIHt5-Qmndb-PtwCsB1QRkZMMPbG5duZS5bO9xXrb_bXn_LLT7f72xbJhyeSe9f_wm92cELzwD1-BvEP2KWm4Q |
CitedBy_id | crossref_primary_10_1002_cmdc_202300128 |
Cites_doi | 10.1111/j.1399-3011.1997.tb01122.x 10.1021/jm9904598 10.1002/anie.201304773 10.1038/s41598-018-37186-2 10.1021/jacs.1c05922 10.1016/j.jhin.2010.09.021 10.1002/anie.200805900 10.4155/fmc.12.75 10.3389/fpubh.2019.00151 10.1128/AAC.21.2.310 10.1021/acs.orglett.6b01437 10.1021/acs.orglett.5b03553 10.1021/acs.chemrev.8b00657 10.1021/np3000987 10.1021/acs.jnatprod.7b00341 10.1021/ja809508f 10.1128/AAC.21.2.299 10.1039/C9OB00227H 10.1002/9780470588888 10.2165/11317030-000000000-00000 10.1002/1099-1387(200011)6:11<560::AID-PSC275>3.0.CO;2-I 10.1021/jo016088w 10.1074/jbc.274.1.29 10.1073/pnas.1812779115 10.1093/toxsci/kfp097 10.1016/0040-4039(94)85198-0 10.1016/j.ddtec.2011.07.005 10.1021/ol053095o 10.1021/cr100048w 10.1021/acsomega.2c05071 10.1002/chem.201705919 10.1002/cbic.201800503 10.1002/chem.200900615 10.1021/ja00805a012 10.1002/med.21639 10.1021/bi992408i 10.1021/acsmedchemlett.1c00251 10.1073/pnas.1525143113 10.1021/ja00722a071 10.1021/acs.chemrev.8b00737 10.1021/cr950005s 10.1529/biophysj.108.137471 10.1039/C9MD00050J 10.1016/0040-4020(67)80037-1 10.1021/ol034907o 10.1111/j.1574-6968.1987.tb02533.x 10.1128/AAC.43.6.1340 10.1021/cr040669e 10.1016/j.tetlet.2018.06.028 10.1055/s-0037-1611691 10.1002/ejoc.201601016 10.1007/s00706-008-0052-z 10.1111/j.1574-6968.2007.00640.x 10.1038/nrd2201 10.1021/np0501536 10.1021/ja00063a082 10.2165/00003495-200464020-00004 10.1038/nrd2590 10.1021/ol101018w |
ContentType | Journal Article |
Copyright | Copyright Royal Society of Chemistry 2023 |
Copyright_xml | – notice: Copyright Royal Society of Chemistry 2023 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7T7 7TM 8FD C1K FR3 P64 7X8 |
DOI | 10.1039/d2ob02126a |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Biotechnology Research Abstracts Technology Research Database Nucleic Acids Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef Biotechnology Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1477-0539 |
EndPage | 169 |
ExternalDocumentID | 36628602 10_1039_D2OB02126A d2ob02126a |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: National Science Foundation grantid: CHE-1827930 – fundername: NIGMS NIH HHS grantid: 1R15GM140412-01 – fundername: NIGMS NIH HHS grantid: R15 GM140412 – fundername: National Science Foundation grantid: CHE-2018399 |
GroupedDBID | --- -DZ -JG -~X 0-7 0R~ 123 29N 4.4 705 70~ 7~J AAEMU AAIWI AAJAE AAMEH AANOJ AAWGC AAXHV AAXPP ABASK ABDVN ABEMK ABJNI ABPDG ABRYZ ABXOH ACGFS ACIWK ACLDK ACNCT ACPRK ADMRA ADSRN AEFDR AENEX AENGV AESAV AETIL AFLYV AFOGI AFRAH AFRDS AFVBQ AGEGJ AGKEF AGRSR AGSTE AHGCF ALMA_UNASSIGNED_HOLDINGS ANUXI APEMP ASKNT AUDPV BLAPV BSQNT C6K CS3 D0L DU5 EBS ECGLT EE0 EF- F5P GGIMP GNO H13 HZ~ H~N IDZ J3I M4U N9A O9- OK1 P2P R7B R7C RAOCF RCNCU RNS RPMJG RRA RRC RSCEA SKA SKF SLH TN5 TWZ UCJ VH6 VQA WH7 XSW YNT YZZ AAYXX AFRZK AKMSF ALUYA CITATION R56 CGR CUY CVF ECM EIF NPM 7QO 7T7 7TM 8FD C1K FR3 P64 7X8 |
ID | FETCH-LOGICAL-c3241-e6b750d4cb6596a75032b5daf78e594dcda50e026f22fc2d8d48e38d8d2a444b3 |
ISSN | 1477-0520 1477-0539 |
IngestDate | Fri Jul 11 10:30:53 EDT 2025 Mon Jun 30 12:02:51 EDT 2025 Mon Jul 21 06:01:12 EDT 2025 Thu Apr 24 23:07:17 EDT 2025 Tue Jul 01 01:52:25 EDT 2025 Tue Dec 17 20:58:24 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3241-e6b750d4cb6596a75032b5daf78e594dcda50e026f22fc2d8d48e38d8d2a444b3 |
Notes | https://doi.org/10.1039/d2ob02126a Electronic supplementary information (ESI) available. See DOI ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-9175-4179 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11311250 |
PMID | 36628602 |
PQID | 2771272503 |
PQPubID | 2047497 |
PageCount | 14 |
ParticipantIDs | pubmed_primary_36628602 proquest_miscellaneous_2764443796 proquest_journals_2771272503 crossref_citationtrail_10_1039_D2OB02126A crossref_primary_10_1039_D2OB02126A rsc_primary_d2ob02126a |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-02-01 |
PublicationDateYYYYMMDD | 2023-02-01 |
PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Cambridge |
PublicationTitle | Organic & biomolecular chemistry |
PublicationTitleAlternate | Org Biomol Chem |
PublicationYear | 2023 |
Publisher | Royal Society of Chemistry |
Publisher_xml | – name: Royal Society of Chemistry |
References | El-Faham (D2OB02126A/cit32/1) 2009; 15 Karaiskos (D2OB02126A/cit14/1) 2019; 7 Engler (D2OB02126A/cit11/1) 1973; 95 Tyndall (D2OB02126A/cit6/1) 2005; 105 Schmidt (D2OB02126A/cit24/1) 1997; 49 Renau (D2OB02126A/cit59/1) 1999; 42 Huber (D2OB02126A/cit10/1) 2018; 24 Carpino (D2OB02126A/cit42/1) 1993; 115 Ellison (D2OB02126A/cit58/1) 2007; 269 Guo (D2OB02126A/cit19/1) 2018; 19 Goodman (D2OB02126A/cit39/1) 1967; 23 Shinde (D2OB02126A/cit37/1) 2015; 7 Wu (D2OB02126A/cit52/1) 1999; 274 Humphrey (D2OB02126A/cit7/1) 1997; 97 Singh (D2OB02126A/cit46/1) 2002; 67 Chow (D2OB02126A/cit1/1) 2019; 119 Boyer (D2OB02126A/cit48/1) 2022; 7 Wang (D2OB02126A/cit44/1) 2021; 143 Cameron (D2OB02126A/cit30/1) 2019; 17 Oren (D2OB02126A/cit8/1) 2000; 39 Carpino (D2OB02126A/cit43/1) 1994; 35 Fairweather (D2OB02126A/cit27/1) 2010; 12 Pérez-Victoria (D2OB02126A/cit38/1) 2012; 75 Thorstholm (D2OB02126A/cit5/1) 2012; 9 Wong (D2OB02126A/cit25/1) 2013; 52 Silvestri (D2OB02126A/cit50/1) 2021; 12 Driggers (D2OB02126A/cit9/1) 2008; 7 Payne (D2OB02126A/cit13/1) 2007; 6 Li (D2OB02126A/cit34/1) 2017; 80 Liu (D2OB02126A/cit20/1) 2019; 30 Almeida (D2OB02126A/cit33/1) 2016; 18 Kropinski (D2OB02126A/cit55/1) 1982; 21 Gunjal (D2OB02126A/cit29/1) 2018; 59 Riehl (D2OB02126A/cit49/1) 2010 Bock (D2OB02126A/cit28/1) 2006; 8 Davison (D2OB02126A/cit21/1) 2019; 10 El-Faham (D2OB02126A/cit41/1) 2011; 111 Heesterbeek (D2OB02126A/cit15/1) 2019; 9 El Haddadi (D2OB02126A/cit23/1) 2000; 6 May (D2OB02126A/cit16/1) 2018; 115 Montero (D2OB02126A/cit45/1) 2009; 131 Li (D2OB02126A/cit17/1) 2004; 64 Zhang (D2OB02126A/cit22/1) 2017; 2017 Lang (D2OB02126A/cit36/1) 2005; 68 Sarojini (D2OB02126A/cit3/1) 2019; 119 Meutermans (D2OB02126A/cit26/1) 2003; 5 Smith (D2OB02126A/cit51/1) 2009; 110 Roxin (D2OB02126A/cit4/1) 2012; 4 Brimble (D2OB02126A/cit31/1) 2020; 31 Jelokhani-Niaraki (D2OB02126A/cit53/1) 2008; 95 Guo (D2OB02126A/cit12/1) 2016; 18 Jing (D2OB02126A/cit2/1) 2020; 40 Li (D2OB02126A/cit18/1) 2009; 69 Dahiya (D2OB02126A/cit35/1) 2009; 140 Lomovskaya (D2OB02126A/cit60/1) 1999; 43 Angus (D2OB02126A/cit54/1) 1982; 21 Kinana (D2OB02126A/cit61/1) 2016; 113 Angus (D2OB02126A/cit56/1) 1987; 48 Kemp (D2OB02126A/cit40/1) 1970; 92 Horne (D2OB02126A/cit47/1) 2009; 48 Clayborn (D2OB02126A/cit57/1) 2011; 77 |
References_xml | – issn: 2010 publication-title: Mirror-Image Asymmetry doi: Riehl – volume: 49 start-page: 67 year: 1997 ident: D2OB02126A/cit24/1 publication-title: J. Pept. Res. doi: 10.1111/j.1399-3011.1997.tb01122.x – volume: 42 start-page: 4928 year: 1999 ident: D2OB02126A/cit59/1 publication-title: J. Med. Chem. doi: 10.1021/jm9904598 – volume: 52 start-page: 10212 year: 2013 ident: D2OB02126A/cit25/1 publication-title: Angew. Chem., Int. Ed. doi: 10.1002/anie.201304773 – volume: 9 start-page: 1 year: 2019 ident: D2OB02126A/cit15/1 publication-title: Sci. Rep. doi: 10.1038/s41598-018-37186-2 – volume: 143 start-page: 12784 year: 2021 ident: D2OB02126A/cit44/1 publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.1c05922 – volume: 77 start-page: 129 year: 2011 ident: D2OB02126A/cit57/1 publication-title: J. Hosp. Infect. doi: 10.1016/j.jhin.2010.09.021 – volume: 48 start-page: 4718 year: 2009 ident: D2OB02126A/cit47/1 publication-title: Angew. Chem., Int. Ed. doi: 10.1002/anie.200805900 – volume: 4 start-page: 1601 year: 2012 ident: D2OB02126A/cit4/1 publication-title: Future Med. Chem. doi: 10.4155/fmc.12.75 – volume: 7 start-page: 1 year: 2019 ident: D2OB02126A/cit14/1 publication-title: Front. Public Health doi: 10.3389/fpubh.2019.00151 – volume: 21 start-page: 310 year: 1982 ident: D2OB02126A/cit55/1 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.21.2.310 – volume: 18 start-page: 3338 year: 2016 ident: D2OB02126A/cit12/1 publication-title: Org. Lett. doi: 10.1021/acs.orglett.6b01437 – volume: 18 start-page: 528 year: 2016 ident: D2OB02126A/cit33/1 publication-title: Org. Lett. doi: 10.1021/acs.orglett.5b03553 – volume: 119 start-page: 9971 year: 2019 ident: D2OB02126A/cit1/1 publication-title: Chem. Rev. doi: 10.1021/acs.chemrev.8b00657 – volume: 75 start-page: 1210 year: 2012 ident: D2OB02126A/cit38/1 publication-title: J. Nat. Prod. doi: 10.1021/np3000987 – volume: 80 start-page: 2101 year: 2017 ident: D2OB02126A/cit34/1 publication-title: J. Nat. Prod. doi: 10.1021/acs.jnatprod.7b00341 – volume: 131 start-page: 3033 year: 2009 ident: D2OB02126A/cit45/1 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja809508f – volume: 31 start-page: 6 year: 2020 ident: D2OB02126A/cit31/1 publication-title: Synlett – volume: 21 start-page: 299 year: 1982 ident: D2OB02126A/cit54/1 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.21.2.299 – volume: 17 start-page: 3902 year: 2019 ident: D2OB02126A/cit30/1 publication-title: Org. Biomol. Chem. doi: 10.1039/C9OB00227H – volume-title: Mirror-Image Asymmetry year: 2010 ident: D2OB02126A/cit49/1 doi: 10.1002/9780470588888 – volume: 69 start-page: 1555 year: 2009 ident: D2OB02126A/cit18/1 publication-title: Drugs doi: 10.2165/11317030-000000000-00000 – volume: 6 start-page: 560 year: 2000 ident: D2OB02126A/cit23/1 publication-title: J. Pept. Sci. doi: 10.1002/1099-1387(200011)6:11<560::AID-PSC275>3.0.CO;2-I – volume: 67 start-page: 815 year: 2002 ident: D2OB02126A/cit46/1 publication-title: J. Org. Chem. doi: 10.1021/jo016088w – volume: 274 start-page: 29 year: 1999 ident: D2OB02126A/cit52/1 publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.1.29 – volume: 115 start-page: 8852 year: 2018 ident: D2OB02126A/cit16/1 publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1812779115 – volume: 110 start-page: 4 year: 2009 ident: D2OB02126A/cit51/1 publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfp097 – volume: 35 start-page: 2279 year: 1994 ident: D2OB02126A/cit43/1 publication-title: Tetrahedron Lett. doi: 10.1016/0040-4039(94)85198-0 – volume: 9 start-page: e13 year: 2012 ident: D2OB02126A/cit5/1 publication-title: Drug Discovery Today: Technol. doi: 10.1016/j.ddtec.2011.07.005 – volume: 8 start-page: 919 year: 2006 ident: D2OB02126A/cit28/1 publication-title: Org. Lett. doi: 10.1021/ol053095o – volume: 111 start-page: 6557 year: 2011 ident: D2OB02126A/cit41/1 publication-title: Chem. Rev. doi: 10.1021/cr100048w – volume: 7 start-page: 37907 year: 2022 ident: D2OB02126A/cit48/1 publication-title: ACS Omega doi: 10.1021/acsomega.2c05071 – volume: 24 start-page: 12107 year: 2018 ident: D2OB02126A/cit10/1 publication-title: Chem. – Eur. J. doi: 10.1002/chem.201705919 – volume: 19 start-page: 2307 year: 2018 ident: D2OB02126A/cit19/1 publication-title: ChemBioChem doi: 10.1002/cbic.201800503 – volume: 15 start-page: 9404 year: 2009 ident: D2OB02126A/cit32/1 publication-title: Chem. – Eur. J. doi: 10.1002/chem.200900615 – volume: 95 start-page: 8005 year: 1973 ident: D2OB02126A/cit11/1 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00805a012 – volume: 40 start-page: 753 year: 2020 ident: D2OB02126A/cit2/1 publication-title: Med. Res. Rev. doi: 10.1002/med.21639 – volume: 39 start-page: 6103 year: 2000 ident: D2OB02126A/cit8/1 publication-title: Biochemistry doi: 10.1021/bi992408i – volume: 12 start-page: 1220 year: 2021 ident: D2OB02126A/cit50/1 publication-title: ACS Med. Chem. Lett. doi: 10.1021/acsmedchemlett.1c00251 – volume: 113 start-page: 1405 year: 2016 ident: D2OB02126A/cit61/1 publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1525143113 – volume: 92 start-page: 5792 year: 1970 ident: D2OB02126A/cit40/1 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00722a071 – volume: 7 start-page: 251 year: 2015 ident: D2OB02126A/cit37/1 publication-title: Der Pharma Chem. – volume: 119 start-page: 10318 year: 2019 ident: D2OB02126A/cit3/1 publication-title: Chem. Rev. doi: 10.1021/acs.chemrev.8b00737 – volume: 97 start-page: 2243 year: 1997 ident: D2OB02126A/cit7/1 publication-title: Chem. Rev. doi: 10.1021/cr950005s – volume: 95 start-page: 3306 year: 2008 ident: D2OB02126A/cit53/1 publication-title: Biophys. J. doi: 10.1529/biophysj.108.137471 – volume: 10 start-page: 693 year: 2019 ident: D2OB02126A/cit21/1 publication-title: MedChemComm doi: 10.1039/C9MD00050J – volume: 23 start-page: 2031 year: 1967 ident: D2OB02126A/cit39/1 publication-title: Tetrahedron doi: 10.1016/0040-4020(67)80037-1 – volume: 5 start-page: 2711 year: 2003 ident: D2OB02126A/cit26/1 publication-title: Org. Lett. doi: 10.1021/ol034907o – volume: 48 start-page: 153 year: 1987 ident: D2OB02126A/cit56/1 publication-title: FEMS Microbiol. Lett. doi: 10.1111/j.1574-6968.1987.tb02533.x – volume: 43 start-page: 1340 year: 1999 ident: D2OB02126A/cit60/1 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.43.6.1340 – volume: 105 start-page: 973 year: 2005 ident: D2OB02126A/cit6/1 publication-title: Chem. Rev. doi: 10.1021/cr040669e – volume: 59 start-page: 2900 year: 2018 ident: D2OB02126A/cit29/1 publication-title: Tetrahedron Lett. doi: 10.1016/j.tetlet.2018.06.028 – volume: 30 start-page: 2279 year: 2019 ident: D2OB02126A/cit20/1 publication-title: Synlett doi: 10.1055/s-0037-1611691 – volume: 2017 start-page: 149 year: 2017 ident: D2OB02126A/cit22/1 publication-title: Eur. J. Org. Chem. doi: 10.1002/ejoc.201601016 – volume: 140 start-page: 121 year: 2009 ident: D2OB02126A/cit35/1 publication-title: Monatsh. Chem. doi: 10.1007/s00706-008-0052-z – volume: 269 start-page: 295 year: 2007 ident: D2OB02126A/cit58/1 publication-title: FEMS Microbiol. Lett. doi: 10.1111/j.1574-6968.2007.00640.x – volume: 6 start-page: 29 year: 2007 ident: D2OB02126A/cit13/1 publication-title: Nat. Rev. Drug Discovery doi: 10.1038/nrd2201 – volume: 68 start-page: 1303 year: 2005 ident: D2OB02126A/cit36/1 publication-title: J. Nat. Prod. doi: 10.1021/np0501536 – volume: 115 start-page: 4397 year: 1993 ident: D2OB02126A/cit42/1 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00063a082 – volume: 64 start-page: 159 year: 2004 ident: D2OB02126A/cit17/1 publication-title: Drugs doi: 10.2165/00003495-200464020-00004 – volume: 7 start-page: 608 year: 2008 ident: D2OB02126A/cit9/1 publication-title: Nat. Rev. Drug Discovery doi: 10.1038/nrd2590 – volume: 12 start-page: 3136 year: 2010 ident: D2OB02126A/cit27/1 publication-title: Org. Lett. doi: 10.1021/ol101018w |
SSID | ssj0019764 |
Score | 2.3984804 |
Snippet | Therapeutic agents with unique molecular structures and new mechanisms of action are needed to confront the phenomenon of multidrug resistance among bacteria.... |
SourceID | proquest pubmed crossref rsc |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 156 |
SubjectTerms | Antibacterial activity Antibiotics Biological Products Chemical compounds Chemical reactions Chemical synthesis Diastereoisomers Molecular Conformation Molecular Structure Multidrug resistance Natural products NMR Nuclear magnetic resonance Peptides Peptides, Cyclic - chemistry Pharmacology Racemization Reagents Selectivity Stereoisomerism Stereoisomers Stereoselectivity |
Title | Diastereoselective synthesis of cyclic tetrapeptide pseudoxylallemycin A illuminates the impact of base during macrolactamization |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36628602 https://www.proquest.com/docview/2771272503 https://www.proquest.com/docview/2764443796 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELVK9wAXxNeyhQUZwQVVKanjOMmxdBctKxYk1EV7qxzbkSK1yWqbSJQbv4y_xkw-nEB7WLikleMkbed1_GzPvCHkjdIhN8pLHCGTxOEqcJ0oZIETw9joJ0YGQVVs4uKzOLvk51f-1WDwqxe1VBbxRP3Ym1fyP1aFNrArZsn-g2XtTaEB3oN94QgWhuOtbHySStQ5MPmmqmaDQUCbbQaUrlEZUVuFGtaFKTDHCpyDNuPrjSl1_n27wiIq663C9Y5xivWO0wx5Z8VEu9xJHOXaXMa1BK-9ghNy3WRv9qltndWpKixhUn9bd3es2ppyFivlulqg_ZZmGBs6vph02z4Y510v_kzqUIDUIs-ubZ-nZlv2o3W-mrSpmN2ULx_PJ_3lDOa1EdDWA_MgcDA4px6g-m216lHrttm0B0-_54OBMYreeA5z3mjvWOF6KLV6wr68R5l7YdVWO0HuvwZKG75Ybdx70bK79g45YAGQtyE5mJ0uPn6yG1nA9qrAhvZbtQq5XvSuu_pPTrQz0QHac9OWo6loz-IBud_MV-isBt9DMjDZI3J33pr0Mfm5C0JqQUjzhNYgpH0Q0l0Q0hntgZDC5bQGId4CQUhrENJdED4hlx9OF_Mzp6nr4Sig71PHiBh4quYqFn4kJO6ks9jXMglC40dcKy1917hMJIwliulQ89B4IbwyyTmPvUMyzPLMHBE6DZQIpUhiN1bcT3TMuQRSLX0MopRTf0Tetr_sUjWi91h7ZbXcteGIvLZ9r2upl729jlsDLRtXsFkycGksgNmENyKv7GkwBO6-yczkJfaBqQeqf4oReVob1j7GE5gh7rIROQRL22bN8rh6qnx2q8_2nNzr_lLHZFjclOYFcOYiftng8jc5Z8cd |
linkProvider | Royal Society of Chemistry |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diastereoselective+synthesis+of+cyclic+tetrapeptide+pseudoxylallemycin+A+illuminates+the+impact+of+base+during+macrolactamization&rft.jtitle=Organic+%26+biomolecular+chemistry&rft.au=Fumo%2C+Vincent+M.&rft.au=Roberts%2C+R.+Charlie&rft.au=Zhang%2C+Jieyu&rft.au=O%27Reilly%2C+Matthew+C.&rft.date=2023-02-01&rft.issn=1477-0520&rft.eissn=1477-0539&rft.volume=21&rft.issue=5&rft.spage=1056&rft.epage=1069&rft_id=info:doi/10.1039%2FD2OB02126A&rft.externalDBID=n%2Fa&rft.externalDocID=10_1039_D2OB02126A |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0520&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0520&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0520&client=summon |